Travere Therapeutics Statistics
NASDAQ: TVTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
52.77-0.67 (-1.25%)
Market open · Delayed 15 min · as of Oct 8, 2:30 PM ET
Travere Therapeutics by the numbers
Travere Therapeutics has a market capitalization of $4.97 billion based on 94.26M shares outstanding. With trailing EPS of $-0.74, Travere Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.2% below its 50-day average and 16.5% above its 200-day average.
Average daily trading volume is 1.58M shares, or about $83.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TVTX valuation vs. peer median
| Metric | TVTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.97B | $5.25B | -5% |
| Forward P/E | 9.4 | 23.4 | -60% |
| Avg. volume | 1.58M | 775.51K | +104% |
Peer median across 8 companies: GRFS, PTCT, COGT, MANE, MIRM, ERAS, DNTH, LGND.
Valuation
- Market cap
- $4.97B
- Forward P/E
- 9.36
- Price / sales (latest FY)
- 10.14
- EPS (TTM)
- $-0.74
- Shares outstanding
- 94.26M
Price and trading
- Previous close
- 53.44
- Open
- 53.44
- Day range
- 51.45 – 53.44
- 52-week range
- 22.59 – 68.73
- 52-week change
- +109.57%
- Beta
- —
- Volume
- 963.92K
- Average volume
- 1.58M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 4.97B
- Forward Pe
- 9.36
- Eps
- -0.74
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 68.73
- Week52 Low
- 22.59
- Avg Volume
- 1.58M
- Shares Outstanding
- 94.26M
- Ma50
- 62.20
- Ma200
- 45.31
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -23.22%
- Pct From52w Low
- 133.60%